skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines trabectedinQuestion & answer

trabectedin · Medicine question

What is the terminal elimination half-life of trabectedin?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Trabectedin has a terminal elimination half-life of 180 hours (population value).

Sources for this answer

Yondelis 0.25 mg powder for concentrate for solution for infusionImmedica · emc · SmPC §5.2 Pharmacokinetic properties · Version 23Document updated 1 October 2025

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

trabectedin

More questions about trabectedin

Can trabectedin cause fatal capillary leak syndrome?Can trabectedin cause rhabdomyolysis?For how long is breastfeeding contraindicated during and after trabectedin treatment?For which adults with advanced soft tissue sarcoma is trabectedin (Yondelis) indicated?For which type of ovarian cancer is trabectedin (Yondelis) indicated in combination with pegylated liposomal doxorubicin?How does ketoconazole affect exposure to trabectedin?

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the trabectedin guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX